Printer Friendly

Oral Health of Patients Treated with Acrylic Partial Dentures Using a Toothpaste Containing Bee Product.

1. Introduction

Oral health and condition reflect body's general health. Condition of the oral cavity, level of hygiene, and residing pathogens affect the whole human organism. There are numerous reports on oral bacteria being the cause of bacterial endocarditis, pneumonia, gastric infections, chronic obstructive pneumonia, and other diseases [1]. The risk of contracting the above-mentioned diseases increases with age. Moreover, the amount of patients who use dentures, which are yet another place of accumulation of microorganisms associated with these infections, rises with age as well. Absences of teeth are closely related to both oral and general health [2]. Loss of a single tooth may cause rotation, shifting, and tipping of neighbouring teeth towards the empty space, which will in turn lead to adverse loads on these teeth, not along the long axis of the tooth [3-5]. Partial lack of teeth, especially in lateral teeth, may cause the loss of mandibular occlusal support, which leads to changes in its position in relation to the maxilla [6]. Such a shift in mandibular position may result in muscle fatigue and other perpetuated occlusal relations in temporomandibular joints [7,8].

Prosthetic treatment is not only designed to restore partial lacks of teeth. It also serves a prophylactic purpose by preventing the formation of pathological changes in the stomatognathic system and removing already existing changes [9]. It is common to employ acrylic partial dentures. Such dentures shift the loads through mucous membrane and periosteum to the bone, restoring masticatory function to a limited extent, do not protect the residual dentition, cause periodontitis and mucositis, create favourable conditions for the accumulation of bacterial plaque, and accelerate the loss of alveolar process. Due to the adverse impact of partial dentures on the denture medium and residual dentition it is necessary to maintain proper oral hygiene, remove plaque carefully, and take preventive measures against caries and periodontopathy [10,11]. Regardless of the type of prosthetic restoration chosen, the maintenance of proper denture and oral hygiene is indispensable to achieve a successful treatment outcome [12].

The oral cavity constitutes a natural environment for microflora, whose composition is an individual feature. It is influenced by, inter alia, age, topography of the oral cavity, condition of teeth, nutritional and breathing habits, tobacco smoking, oral hygiene, and loss of teeth or usage of prosthetic restorations [13]. The extent of such changes depends on the type of dentures: fixed dentures cause local changes in the microflora, while removable dentures cause more complex changes. It is associated with the formation of new reservoirs of microorganisms such as the intramucosal surface of the denture base or clasps on retaining teeth. Acrylic base of partial dentures covers a substantial surface of the mucosa, creating favourable conditions for the buildup of bacteria and fungi in the form of denture plaque. It is a place characterised by high humidity, elevated temperature, reduced oxygen supply, and impaired conditions for salivary self-cleaning. Moreover, the acrylic material, due to its heterogeneous and porous structure, absorbs water and swells in the oral cavity, further facilitating the aggregation of microorganisms [14-16]. Perfect oral hygiene is also the basic method for prevention of caries and diseases of the periodontium and oral mucosa. Caries and periodontal diseases are the most common cause of teeth loss. Therefore, it is crucial to protect residual dentition in patients with partial dentures from these diseases. The basic hygienic treatment is mechanical removal of plaque, supported by, for example, antimicrobial chemical agents [17,18]. The positive effect of ethanolic extract of propolis and tea tree oil on the maintenance of proper oral hygiene has been known for a long time. They are naturally occurring compounds with a broad-spectrum antimicrobial, antiviral, antifungal, and antiprotozoal activity. Additionally, they exhibit antiphlogistic and antioxidant properties [19,20].

Propolis, so-called bee glue, is made by bees mostly from resinous substances gathered from buds of some trees. Its properties depend on the species of bees which produce it as well as on the plants used for the production [21]. Propolis is a very complex substance with high contents of active ingredients like flavonoids, phenols, aromatic acids, esters, wax substances, aldehydes, coumarin, sterols, enzymes, or fatty acids, as well as proteins, microelements, and vitamins [22,23]. Propolis is well-soluble in ethyl alcohol; thus medical extracts can easily be prepared [23]. In dentistry propolis is used in the treatment of caries [24] and periodontal diseases [20,25]. It also exhibits analgesic activity and accelerates wound healing, which is used in dental surgery [26]. There are numerous scientific reports on its anticancer, antiphlogistic, and immunomodulating properties [19,27]. Tea tree oil is obtained from leaves of a tree growing in Australia and New Zealand, Melaleuca alternifolia, using cold water extraction [28].

Tea tree oil is a mixture of terpene compounds, such as terpinen-4-ol, [gamma]-terpinene, p-cymene, [alpha]-terpinene, and 1,8-cineole, which are largely responsible for tea tree oil's properties [29,30]. TTO exhibits strong antiseptic activity, selective for pathogenic microorganisms, and is highly effective against oral cavity pathogens [31]. It has also been demonstrated that TTO has inhibitory properties against Candida albicans [32].

The study aims to assess the influence of toothpastes containing ethanolic extract of propolis and tea tree oil on oral hygiene in patients with partial dentures. The number of scientific reports on synergistic activity of these substances in the improvement of oral hygiene is insufficient [33,34]. The aim of this study was to evaluate the influence of toothpaste with active substances of plant origin, such as ethanolic extract of propolis and tea tree oil, on microflora of the oral cavity and to evaluate the following indices: OHI-S, denture plaque index, mSBI, and API in patients with partial dentures.

2. Materials and Methods

This study was conducted between September 1, 2015, and March 1, 2016, in the Department of Prosthetic Dentistry, Akademickie Centrum Stomatologii i Medycyny Specjalistycznej (Bytom, Poland), and in Specialist Dental Clinic (Katowice, Poland), which provide comprehensive dental care for patients with removable dentures.

2.1. Toothpaste Preparations with Propolis and Tea Tree Oil. Two samples of toothpaste covered anonymously with blank white tag and marked only with letter A or C were compared: the studied toothpaste with the active ingredient (study group, A), 1,5% content of ethanol extract of Polish propolis, and with no active ingredients, placebo (control group, C). The second natural product valued for its properties was tea tree oil (TTO). It is obtained from the Melaleuca alternifolia plant. Two other species (Melaleuca linariifolia and Melaleuca dissitiflora) are also used to obtain essential oil, only if they contain more than 30% terpinen-4-ol in the essential oil. The major component of tea tree oil is terpinen-4-ol. Its content is 29-45%. The composition of active and placebo toothpaste had the following:

Active Toothpaste

aqua (up to 100% of weight),

glycerine (5-12%),

silica (10-14%),

sorbitol (10-20%),

hydroxyethyl cellulose (0.1-1%),

titanium dioxide (0.5-2%),

xanthan gum (0.3-1%),

ethanolic extract of propolis (EEP) (1.0%),

tea tree oil (TTO) (1.0%),

menthol oil (0.2%),

rosemary oil (0.1%).

Placebo Toothpaste





hydroxyethyl cellulose,

titanium dioxide,

xanthan gum.

2.2. Study Groups Inclusion and Extrusion Criteria. Subject qualification for the study was based on medical and dental history, interview, and review of clinical records. The exclusion and inclusion criteria from the investigation were as follows:

Inclusion Criteria

(i) written participation consent,

(ii) age (40-85 years),

(iii) patients lacking 5-8 teeth in the maxilla and mandible under prosthetic treatment,

(iv) patients with remaining posterior occluding pairs with a minimum of two supporting zones according to Eichner index.

Extrusion Criteria

(i) lack of a written participation consent, painful masticatory dysfunction,

(ii) edentulous patients or patients with residual dentition (Eichner subgroups C1-C3), patients with full dental arches or lacking 1-2 teeth in an arch,

(iii) patients with retaining teeth mobility over +20 PTV tested with the Periotest instrument,

(iv) patients with class V fillings or acrylic/ceramic crowns around the retaining teeth,

(v) patients with cancer,

(vi) psychosomatic disorders,

(vii) patients after trauma within the craniofacial region,

(viii) pregnant and lactating females,

(ix) patients suffering from asthma or atopic dermatitis, allergic to foods, drugs, or honey and its products, or having other allergy-related ailments.

The study was conducted with the prior approval from the Bioethics Committee of the Silesian Medical Chamber in Katowice, Poland, Resolution number 8/2015 of March 23, 2015.

2.3. Patients. 37 patients aged 41-82 (57.0 [+ or -] 10.49) were qualified for the study, including 20 females (54%) and 17 males (46%). Patients were randomly divided into two subgroups. The study group consisted of 18 persons aged 41-79 (55.05 [+ or -] 11.09), who received the active toothpaste with propolis and tea tree oil, whereas the control group consisted of 19 patients aged 41-82 (66.79 [+ or -] 11.19), who were given the negative control toothpaste.

2.4. Clinical Examination Protocol. The studies were performed in two stages. The first stage consisted of a general medical and dental interview based on a survey and a form written particularly for this purpose. The study was extended by a survey concerning medical history and current diseases, allergies, taken medication, and environmental risk. Mobility of the retaining tooth was also measured with Periotest during the first visit, as a criterion qualifying the patient for the study. The values may be in the following ranges: -08 to +09, physiological teeth mobility; +10 to +19, perceptible teeth mobility; +20 to +29, moderate teeth mobility under investigator's pressure; +30 to +50, severe teeth mobility under pressure from the lips or tongue [35,36]. Patients qualified for the study were evaluated to determine the value of selected oral hygiene indices included in the form, that is, OHI-S, denture plaque index, mSBI, and API. The measurement procedure according to the above-mentioned indices was carried out with use of a standard WHO periodontal probe. The measurement was based on the assessment of presence and size of plaque on selected tooth surfaces and bleeding from the interdental papilla.

Approximal Plaque Index (API), Lange and Ainamo, 1988: Presence of plaque is assessed only on occlusal surfaces. The presence of bacterial plaque is examined in quadrants 1 and 3 on occlusal surfaces on the side of the oral cavity proper and in quadrants 2 and 4 on occlusal surfaces on the side of the vestibule. The formula used to calculate the value of API [%] = the sum of interdental spaces with plaque/the sum of all examined surfaces x 100%. Index values were interpreted as follows: API 100-70%, bad oral hygiene; API 70-40%, average hygiene, improvement recommended; API 39-25%, quite good oral hygiene; API < 25%, optimal oral hygiene.

Simplified Oral Hygiene Index determines the amount of soft debris or calculus on the four buccal surfaces of the selected teeth: upper right first molar, upper right central incisor, upper left first molar, and lower central incisor, and on the lingual surfaces of the lower left first molar and lower right first molar.

Denture plaque index (Budtz-Jorgensen, 1978) provides the following description for the amount of denture plaque on the fitting surface: 0 = nonvisible, 1 = less than one-third covered, 2 = one-third to two-thirds covered, and 3 = more than two-thirds covered.

The periodontal status (gingival health) was evaluated with use of the modified Sulcus Bleeding Index (mSBI, Muhlemann-Son, 1971) and by recording only "bleeding presence" or "bleeding absence" for all existing teeth. The index describes the presence of localised bleeding in interdental spaces and interdental papilla. In quadrants 1 and 3 the vestibular side is examined, while in quadrants 2 and 4 the lingual one is examined.

After clinical examination acrylic partial dentures were made for all 37 patients. Both groups (study and control) were subjected to hygienisation of the oral cavity and instructed on how to properly brush their teeth with use of Fones circular technique. Fones circular technique consists of putting the toothbrush perpendicularly to slightly opened dental arches and performing circular movements. In the roll technique the toothbrush is placed on attached gingiva at the angle of 45[degrees] with the bristles pointed towards the root. Patients were also shown the proper denture hygiene. They were instructed to wash their dentures after every meal with use of a soft denture brush or with hands and hard soap. After brushing the dentures were to be carefully rinsed under running water and put in the oral cavity. Patients were advised not to use dentures on a 24/7 basis. Dentures were supposed to be removed for the night and kept in a dry place after prior washing. All patients were examined in three subsequent stages: preliminary qualification at baseline before hygiene procedure (1st assessment), a follow-up after 7 days (2nd assessment), and a follow-up 28 days after the initial examination (3rd assessment). Patients were examined for regression of lesions, frame of mind, and possible side effects, which was recorded on the control form. During each examination swabs were used for microbiological examination of oral cavity microflora. The microbial material for smear tests was collected from the floor of the mouth.

2.5. Bacterial Strains Isolation and Microbiological Investigation. Microbiological examinations were performed with use of classic methods employed in microbiological diagnostics. Material collected from the patients was cultured on proper growth media for proliferation and subsequent isolation of pure cultures. Aerobic bacteria were proliferated on Columbia agar solid medium with 5% sheep blood at 37[degrees]C. Anaerobic bacteria were proliferated on Schaedler K3 solid medium with 5% sheep blood at 37[degrees]C in anaerobic conditions obtained with Biomerieux GENbag anaer generators (Marcy-l'Etoile, France). Species identification was performed after isolation and proliferation of cultured microorganism strains with use of the following reagent sets: ENTEROtest 24N, NEFERMtest 24N, STREPTOtest 24, STAPHYtest, ANAEROtest 23, OXItest, PYRAtest, and TNW lite 6.5 computer program for species identification of microorganisms (Erba-Lachema, Brno, Czech Republic). Also the following Biomerieux (Marcyl'Etoile, France) biochemical tests were used: Katalaza, Slidex Staph Kit, and API Candida. Performance and interpretation of results of the tests was carried out according to the manufacturer's recommendations with diagnostic reagent sets.

2.6. Statistical Analysis. The first stage of statistical analysis consisted of verification of the compatibility of the obtained index values and the number of bacteria with normal distribution with use of the Shapiro-Wilk test. Variables with normal distribution were presented with arithmetic mean and standard deviation, whereas nonparametric variables were presented with median and interquartile range. One-way analysis of variance (ANOVA) and Levene's test were used to compare the results of the study group with the control group for OHI, denture plaque index, and the number of bacteria. The comparison of results between groups was performed with the Tukey-Kramer method. Results obtained for OHI and denture plaque index were compared with Student's t-test for dependent and independent samples. For unrelated variables of API and SBI the results of study and control groups were compared with Mann-Whitney U test, Wilcoxon signed-rank test, and Friedman's ANOVA with Kendall's coefficient of concordance. The results were deemed to be statistically significant if p < 0.05.

3. Results

3.1. Oral Health Conditions. The general distribution range for API was presented in Table 1. Statistically significant differences between groups were reported 7 and 28 days after the initial examination (p < 0.05 and p < 0.001). Improvement of hygiene was reported both in the study group (A) and in the control group (C). It may be associated with the reduction of interproximal spaces in the lateral segments of maxilla and/or mandible. A significant improvement was only observed in the study group (A) (Table 1).

Another assessed index was the simplified Greene-Vermilion hygiene index. Statistically significant improvement of hygiene in the study group (A) was observed (Table 2). In the study group (A) the index was determined after 7 and 28 days of usage (p = 0.013221, p = 0.000468). No statistical significance was observed in the control group (C) (Table 2). Significant reduction was observed by comparing OHI 7 and 28.

Based on the conducted analysis of denture plaque index values no significant reduction in the values was observed after the period of use of toothpastes in study (A) and control (C) groups compared to the output value (Figure 1).

Statistically significant reduction of gingival bleeding index after 7 and 28 days of the use of toothpastes compared to the gingival bleeding index at the beginning of the treatment was observed both in study (A) and in the control group (C) (Table 3). The study and control group did not differ in terms of the assessment of the SBI value upon initial examination. After 7 and 28 days of use the control group exhibited a significantly higher level of SBI in comparison with the study group (Table 3).

3.2. Microbiological Investigation. The following observations in study group (A) constituted by 18 patients were made: 77 microorganisms of 31 species were isolated in the first microbiological test. The second test (after 7 days of use of the toothpaste with EEP and TTO) resulted in the isolation of 78 microorganisms of 27 species. The third test after 4 weeks of use of the active toothpaste showed a decrease in the number of isolated microorganisms to 65, of 24 species (Table 4). The oral microflora diversity was reduced by the decrease in the number of cultured microorganism species. The following bacterial species were eliminated: Actinomces viscocus, Actinomyces israelii, Atopobium parvulum, Bifidobacterium ovatus, Clostridiumbotulinum, Eubacterium saburreum, Lactobacillus acidophilus, Lactobacillus fermentum, and Propionibacterium granulosum, classified as Gram(+) anaerobes. They are all part of the oral flora and, more specifically, dental biofilm bacteria. Lactobacillus acidophilus is a known pathogen responsible for the development of caries. Actinomyces spp. belong to pioneer bacteria responsible for the formation of plaque, while A. israeli may be an etiological factor for actinomycosis. The following species were also eliminated: Bacteroides uniformis and Parabacteroides distasonis classified as Gram(-) anaerobes; Acinetobacter freundii, Burkholderia cepacia, and Neisseria sicca (Gram(-) aerobe), as well as Staphylococcus epidermidis MSCNS (Gram(+) aerobe), which can cause opportunistic infections, including sepsis.The microflora gained the following species, Gram(+) anaerobes: Atopobium minutum and Clostridium butyricum, Gram(-) anaerobes: Capnocytophaga ochracea and Prevotella melaninogenica, Gram(+) aerobes: Microccus spp. and Streptococcus oralis, and Gram(-) aerobes: Providencia rustigiani and Stenotrophomonas maltophilia. Micrococcus spp. and S. oralis are classified as microorganisms which participate in plaque formation as one of the first. Capnocytophaga ochracea belongs to the green bacterial complex, associated with advanced periodontitis according to Socransky. In our study the number of the following bacteria declined: Bifidobacterium adolescentis, Veillonella parvula, Streptococcus salivarius, and Streptococcus sanguinis. They all belong to physiological bacterial flora and participate in the formation of dental biofilms. A reduction of Candida albicans was also observed (Table 5). C. albicans is often isolated from the oral cavity, although most frequently in patients using dentures, and does not always cause infection symptoms.

In the control group (C) constituted by 19 patients, 79 microorganisms of 25 species were isolated in the first microbiological test. The second test resulted in the isolation of 83 microorganisms of 28 species, while the third test after 4 weeks of use of the toothpaste without active ingredients resulted in the culture of 92 microorganisms of 26 species (Table 4). An increase of the number of cultured microorganisms and a slight increase in the number of species were observed. The following species were eliminated: Gram(+) anaerobes: Clostridium sporogenes, Eubacterium saburreum, and Lactobacillus fermentum, and Gram(-) anaerobes: Bacteroides ovatus, Bacteroides uniformis, Fusobacterium mortiferum, and Prevotella oralis, as well as Gram(+) aerobic bacterium Staphylococcus aureus MSSA. The microflora gained the following Gram(+) anaerobes: Bifidobacterium dentium, Bifidobacterium ovatus, Clostridium chauvoei, Gemella morbillorum, and Propionibacterium propionicum. Bifidobacterium spp. are probiotic bacteria dwelling in human intestine. Gemella morbilorum is a pathogen isolated from cysts whichwere not resolved after the second attempt of endodontic treatment. The flora also gained Gram(-) anaerobic bacterium Veillonella parvula, Gram(+) aerobic bacterium Streptococcus mutans, and Gram(-) aerobic bacterium Neisseria sicca. Streptococcus spp. participate in plaque formation, while S. mutans is a known etiological factor for caries. V. parvula, which belongs to the purple complex according to Socransky, is isolated in patients with healthy periodontium. The number of cultured Candida albicans also increased. As mentioned before, this fungus is often isolated in patients with removable dentures. The number of the following bacteria declined in the control group: Blautia producta, Clostridium clostridiforme, Lactobacillus acidophilus, Capnocytophaga ochracea, and Streptococcus sanguinis, and the number of the following bacteria increased: Actinomyces israelii, Actinomyces naeslundii, Campylobacter gracilis, Streptococcus mitis, Streptococcus salivarium, Escherichia coli, and Neisseria subflava, as well as fungi Candida albicans (Table 5).

3.3. Side Effects. No serious side effects have been reported. Some patients reported discoloration of their toothbrush.

4. Discussion

Natural extracts used in the tested toothpastes were intended to provide chemical assistance in the mechanical removal of plaque and thus improve oral hygiene. The first one was Evidence-Based Complementary and Alternative Medicine 7 ethanolic extract of propolis. There are numerous studies confirming its strong antimicrobial, antiviral, antifungal, and antiphlogistic activity [37-39]. Propolis exhibits a wide spectrum of antimicrobial activities. Research conducted by Koru et al. demonstrated that propolis is more effective against Gram(+) aerobes than against Gram(-) aerobes [40]. In their study Feres et al. compared antimicrobial activity of 11% propolis and the popular 0.12% chlorhexidine against bacteria in saliva in healthy patients and in patients with periodontal diseases. Both substances exhibited statistically significant antimicrobial activity [41]. Antimicrobial activity of 10% propolis and 0.12% chlorhexidine against S. mutans and L. acidofilus, known pathogens responsible for the development of caries, was compared in 2011. Both proved to be effective [42].Another study from 2013 compared 0.12% chlorhexidine with propolis at a much lower concentration, namely, 2%. Its antimicrobial activity against S. mutans and L. acidofilus was confirmed [43]. These studies proved the cariostatic properties of propolis, antiperiodontal pathogen activity, and efficiency at lower concentrations. In the present study we employed 1.5% ethanolic extract of propolis. Hitherto, there have been no studies confirming the antimicrobial effectiveness at the concentration of 1.5%. However, in the toothpaste tested it was combined with tea tree oil, which has similar properties.Thus, the concentration of EEP could be lowered. At the same time, lower concentration of EEP minimises the risk of side effects such as allergic reactions and burning sensation in the oral cavity [34]. An important aspect is the antiphlogistic properties of ethanolic extract of propolis [44]. Skaba et al. conducted an analysis of ethanolic extract of Brazilian propolis, in which they confirmed its antiphlogistic activity using three recognised methods. The same study included an assessment of the influence of toothpastewith 3% ethanolic extract of Brazilian propolis on oral hygiene with use of oral cavity indices: API, OHI, and SBI. Researchers collected also smears from patients in order to assess antimicrobial activity. Patients were divided into two groups. The study group (I) was using an active toothpaste (T) with propolis, while the control group (II) was using a toothpaste with no active substance (G). Patients were examined on the first, initial visit, second visit after a week, and third one after 4 weeks. After 4 weeks of using the T toothpaste there was a statistically significant decrease in OHI in both groups I and II, which may indicate that daily mechanical plaque removal, even without active substances, can be effective in healthy patients. API in group II did not change and patients were qualified for the group with average hygiene, whereas API in group I improved after 7 days and returned to baseline upon the last examination, patient with quite good hygiene. SBI improved in group I, but in a statistically insignificant way. It did not change in group II [45]. Study of toothpastes with 3% ethanolic extract of propolis in patients undergoing orthodontic treatment was conducted in 2013 and in 2016. Apart from the smears, it comprised also API according to Lange, Gingival Index (GI), and Orthodontic Plaque Index (OPI) upon first examination and after 35 days of using a toothpaste with propolis and CT gel. The control group consisted of patients using a toothpaste without propolis and CC gel. The first examination did not demonstrate any statistically significant differences in the assessed indices. Upon examination after 35 days there was a statistically significant decrease in the values of GI and OPI compared to the control group. No significant difference was shown in the decrease of API [46,47].

Melaleuca alternifolia tea tree oil (TTO) is also a known antiseptic preparation with antimicrobial and antifungal activity. It has been successfully used for many centuries in dermatology, particularly in the treatment of acne vulgaris [48], accelerates wound healing, and has anticancer properties [49]. The basic composition of the oil is terpinen-4-ol, [gamma]-terpinene, [alpha]-terpinene, 1,8-cineole, terpinolene, [rho]-cymene, [alpha]-pinene, [alpha]-terpineol, aromadendrene, [delta]-cadinene, limonene, sabinene, globulol, and viridiflorol. They are terpene compounds with antiseptic and antiphlogistic activities which apart from dermatology can also be employed in dentistry, particularly in the maintenance of proper oral hygiene [50]. In 2003 Hammer et al. examined in vitro the antimicrobial activity of tea tree oil against 161 isolated oral pathogens and detected MIC and MBC for 15 of them. MIC and MBC values were lowest for Porphyromonas spp., Prevotella spp., and Veillonella spp. and highest for isolated Streptococcus spp., Fusobacterium spp., and Lactobacillus spp. Time necessary for the death of Streptococcus mutans and Lactobacillus rhamnosus in [greater than or equal to]0.5% concentration was 5 minutes. It was thus demonstrated that oral pathogens are susceptible to the activity of TTO [51].

Studies on toothpastes with natural extracts against three species of bacteria S. mutans, P. aeruginosa, and E. faecalis compared to a toothpaste without antimicrobial ingredients were conducted in 2015. S. mutans is a known etiological factor for caries, while P. aeruginosa and E. faecalis are pathogens isolated in periodontopathies and endodontic infections. 8 toothpastes with the following composition were used: sorbitol (I), tocopherol (II), mentha (III), cinnamon/ mentha (IV), propolis/tea tree oil (V), mentha/acai berry (VI), mentha/guarana (VII), and propolis (VIII). The control group was a toothpaste with no antimicrobial properties (group (IX), negative control), while group (X) (positive control) was a dental gel with triclosan and formaldehyde. The results demonstrated that E. faecalis exhibited resistance to the toothpaste with propolis and tea tree oil and susceptibility to the toothpaste with propolis only. The authors explain it with a different concentration of propolis in the toothpastes. Propolis/tea tree oil toothpaste exhibited the strongest antimicrobial activity against S. mutans compared to other toothpastes. P. aeruginosa proved to be resistant to all tested natural substances [52]. Some other researchers demonstrate alternative methods to reduce pathological oral microflora, by addition to resin composites on element ions with nanogold and nanosilver [53,54].

In the present study there was an increase in the number of cultured C. albicans colonies in patients using both the active toothpaste and the placebo. Both active substances employed in the active toothpaste exhibit antifungal activity. However, it should be remembered that the group of examined patients was using acrylic partial dentures, which are an iatrogenic factor for C. albicans infection [55]. The use of acrylic partial dentures caused changes in the oral microflora. The acrylic material is a reservoir for C. albicans, whose amount depends on denture hygiene and its quality, particularly roughness [56,57]. The 2011 study of bee products in comparison with fluconazole confirmed the antifungal activity of propolis and the possibility of its alternative use in antifungal therapy. It exhibits activity against C. albicans, C. glabrata, C. krusei, and Trichosporon spp. [58]. There are many reports on the antifungal activity of tea tree oil. The 2003 in vitro study examined the antifungal activity of particular components of the oil in concentrations between 0.5% and 2%. The results demonstrated that all components of the oil, apart from [beta]-myrcene, exhibit antifungal activity [59]. The study from 2004 confirmed the hypothesis of the mechanism of action of tea tree oil against C. albicans, C. glabrata, and S. cerevisiae. The oil influences the properties and disrupts the functions of fungal cell membrane [60]. Study conducted by Sudjana et al. demonstrated that TTO inhibits adhesion of C. albicans to human cells and polystyrene and inhibits the formation of biofilm through reduction of surface tension [61].

5. Conclusions

(1) Improvements in hygiene and the condition of periodontium were observed in patients using toothpastes with ethanolic extract of propolis and tea tree oil.

(2) The toothpaste with ethanolic extract of propolis and tea tree oil had no influence on the reduction of denture plaque.

(3) The studied toothpaste with active ingredients (ethanolic extract of propolis and tea tree oil) demonstrates the beneficial influence on microorganisms composition in oral microflora.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


[1] L. Coulthwaite and J. Verran, "Potential pathogenic aspects of denture plaque," British Journal of Biomedical Science, vol. 64, no. 4, pp. 180-189, 2016.

[2] D. A. Felton, "Edentulism and comorbid factors," Texas Dental Journal, vol. 127, no. 4, pp. 389-401, 2010.

[3] J. M. Dersot and J. L. Giovannoli, "Posterior bite collapse. 1. Etiology and diagnosis," Journal de Parodontologie, vol. 8, no. 2, pp. 187-194, 1989.

[4] J. L. Giovannoli and J. M. Dersot, "Posterior bite collapse. 2. Therapeutic proposals," Journal de parodontologie, vol. 10, no. 1, pp. 21-30, 1991.

[5] A. Tallgren, "The continuing reduction of the residual alveolar ridges in complete denture wearers: a mixed-longitudinal study covering 25 years," Journal of Prosthetic Dentistry, vol. 89, no. 5, pp. 427-435, 2003.

[6] J. T. Kelly Jr., "A multidisciplinary approach to restoring posterior bite collapse," Compendium of Continuing Education in Dentistry, vol. 18, no. 5, pp. 483-489, 1997.

[7] A. Shifman, B.-Z. Laufer, and H. Chweidan, "Posterior bite collapse--revisited," Journal of Oral Rehabilitation, vol. 25, no. 5, pp. 376-385, 1998.

[8] K. Ikebe, K.-I. Matsuda, R. Kagawa et al., "Masticatory performance in older subjects with varying degrees of tooth loss," Journal of Dentistry, vol. 40, no. 1, pp. 71-76, 2012.

[9] J. Kulczynska, M. Zoltak-Staron, I. Maciejewska, and Z. Bereznowski, "Prosthodontic rehabilitation of partially edentulous patients under the National Health Fund," Protet Stomatol journa, vol. 61, no. 2, pp. 106-113, 2011.

[10] A. L. Almeida, D. T. Catalani, P. C. Oliveira, S. Soares, F. S. Tunes, and K. H. Neppelenbroek, "Assessment of periodontal and hygiene conditions of removable partial dentures in individuals with clefts," The Cleft Palate-Craniofacial Journal, vol. 53, no. 6, pp. 727-731, 2016.

[11] L. J. Dula, E. F. Ahmedi, Z. D. Lila-Krasniqi, and K. S. Shala, "Clinical evaluation of removable partial dentures on the periodontal health of abutment teeth: a retrospective study," Open Dentistry Journal, vol. 9, pp. 132-139, 2015.

[12] B. Frczak, G. Aleksandruk, W. Brzoza, and M. Chrusciel-Nogalska, "Oral and denture hygiene practices of patients using removable prosthetic appliances," Czasopismo Stomatologiczne, vol. 62, no. 3, pp. 202-209, 2009.

[13] I. Espinoza, R. Rojas, W. Aranda, and J. Gamonal, "Prevalence of oral mucosal lesions in elderly people in Santiago, Chile," Journal of Oral Pathology and Medicine, vol. 32, no. 10, pp. 571-575, 2003.

[14] A. Kurnatowska and J. Bieniek, "The level of cariogenic bacteria in wearers of partial dentures," Protetyka Stomatologiczna, vol. 56, no. 2, pp. 130-135, 2006.

[15] A. Kanli, F. Demirel, and Y. Sezgin, "Oral candidosis, denture cleanliness and hygiene habits in an elderly population," Aging Clinical and Experimental Research, vol. 17, no. 6, pp. 502-507, 2005.

[16] S. Khasawneh and A. al-Wahadni, "Control of denture plaque and mucosal inflammation in denture wearers," Journal of the Irish Dental Association, vol. 48, no. 4, pp. 132-138, 2002.

[17] E. Hedman, P. Gabre, and D. Birkhed, "Dental hygienists working in schools--a two-year oral health intervention programme in swedish secondary schools," Oral health & preventive dentistry, vol. 13, no. 2, pp. 177-188, 2015.

[18] X. Li, Y. Zhong, X. Jiang et al., "Randomized clinical trial of the efficacy of dentifrices containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride over two years," Journal of Clinical Dentistry, vol. 26, no. 1, pp. 7-12, 2015.

[19] T. Morawiec, A. Dziedzic, I. Niedzielska et al., "The biological activity of propolis-containing toothpaste on oral health environment in patients who underwent implant-supported prosthodontic rehabilitation," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 704947, 12 pages, 2013.

[20] T. Morawiec, A. Mertas, R. D. Wojtyczka et al., "The assessment of oral microflora exposed to 3% ethanolic extract of Brazilian green propolis preparation used for hygiene maintenance following minor oral surgeries," BioMed Research International, vol. 2015, Article ID 869575, 10 pages, 2015.

[21] R. D. Wojtyczka, R. Kubina, A. Kabala-Dzik, R. J. Buldak, A. Kabala-Dzik, and R. J. Buldak, "Antibacterial activity of ethanol extract of propolis," Annales AcademiaeMedicae Stetinensis, vol. 66, no. 2, pp. 39-48, 2012 (Polish).

[22] F. A. Santos, E. M. A. Bastos, M. Uzeda et al., "Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria," Journal of Ethnopharmacology, vol. 80, no. 1, pp. 1-7, 2002.

[23] M. G. Miguel and M. D. Antunes, "Is propolis safe as an alternative medicine?" Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 4, pp. 479-495, 2011.

[24] A. Dziedzic, R. Kubina, R. D. Wojtyczka, A. Kabala-Dzik, M. Tanasiewicz, and T. Morawiec, "The antibacterial effect of ethanol extract of polish propolis on mutans streptococci and lactobacilli isolated from saliva," Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 681891, 12 pages, 2013.

[25] W. A. Bretz, N. Paulino, J. E. Nor, and A. J. Moreira, "The effectiveness of propolis on gingivitis: a randomized controlled trial," Journal of Alternative and Complementary Medicine, vol. 20, no. 12, pp. 943-948, 2014.

[26] W. N. Hozzein, G. Badr, A. A. Al Ghamdi, A. Sayed, N. S. Al-Waili, and O. Garraud, "Topical application of propolis enhances cutaneous wound healing by promoting TGF-beta/ smad-mediated collagen production in a streptozotocin-induced type I diabetic mouse model," Cellular Physiology and Biochemistry, vol. 37, no. 3, pp. 940-954, 2015.

[27] M. Viuda-Martos, Y. Ruiz-Navajas, J. Fernandez-Lopez, and J. A. Perez-Alvarez, "Functional properties of honey, propolis, and royal jelly," Journal of Food Science, vol. 73, no. 9, pp. R117-R124, 2008.

[28] J. Karbach, S. Ebenezer, P. H. Warnke, E. Behrens, and B. Al-Nawas, "Antimicrobial effect of australian antibacterial essential oils as alternative to common antiseptic solutions against clinically relevant oral pathogens," Clinical Laboratory, vol. 61, no. 1-2, pp. 61-68, 2015.

[29] O. Hartford and K. A. Zug, "Tea tree oil," Cutis, vol. 76, no. 3, pp. 178-180, 2005.

[30] B. Kedzia, J. Alkiewicz, and S. Han, "Significance of tea tree oil in phytotherapy. Part I. Composition of essential oil and its biological properties," Borgis--Postepy Fitoterapii, vol. 2, pp. 36-40, 2000.

[31] C. F. Carson and T. V. Riley, "Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil," Contact Dermatitis, vol. 45, no. 2, pp. 65-67, 2001.

[32] M. Blonska, J. Bronikowska, G. Pietsz, Z. P. Czuba, S. Scheller, and W. Krol, "Effects of ethanol extract of propolis (EEP) and its 12 Evidence-Based Complementary and Alternative Medicine flavones on inducible gene expression in J774A.1 macrophages," Journal of Ethnopharmacology, vol. 91, no. 1, pp. 25-30, 2004.

[33] M. Corazza, A. Borghi, R. Gallo et al., "Topical botanically derived products: use, skin reactions, and usefulness of patch tests. A Multicentre Italian Study," Contact Dermatitis, vol. 70, no. 2, pp. 90-97, 2014.

[34] M. T. Ventura, M. Viola, G. Calogiuri, F. Gaeta, O. Pesole, and A. Romano, "Hypersensitivity reactions to complementary and alternative medicine products," Current Pharmaceutical Design, vol. 12, no. 26, pp. 3393-3399, 2006.

[35] W. Schulte, B. d'Hoedt, D. Lukas, M. Maunz, and M. Steppeler, "Periotest for measuring periodontal characteristics--correlation with periodontal bone loss," Journal of Periodontal Research, vol. 27, no. 3, pp. 184-190, 1992.

[36] P. Stendera, E. Gawor, and E. Spiechowicz, "Zastosowanie Periotestu do okreslenia ruchomosci zebow przy zwartych lukach zebowych- badania wstepne," Stomatologia W spolczesna, vol. 7, pp. 20-23, 2000.

[37] A. Kujumgiev, I. Tsvetkova, Y. Serkedjieva, V. Bankova, R. Christov, and S. Popov, "Antibacterial, antifungal and antiviral activity of propolis of different geographic origin," Journal of Ethnopharmacology, vol. 64, no. 3, pp. 235-240, 1999.

[38] J. M. Sforcin, A. Fernandes Jr., C. A. M. Lopes, V. Bankova, and S. R. C. Funari, "Seasonal effect on Brazilian propolis antibacterial activity," Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 243-249, 2000.

[39] Y. K. Park, M. H. Koo, J. A. S. Abreu, M. Ikegaki, J. A. Cury, and P. L. Rosalen, "Antimicrobial activity of propolis on oral microorganisms," Current Microbiology, vol. 36, no. 1, pp. 24-28, 1998.

[40] O. Koru, F. Toksoy, C. H. Acikel et al., "In vitro antimicrobial activity of propolis samples from different geographical origins against certain oral pathogens," Anaerobe, vol. 13, no. 3-4, pp. 140-145, 2007.

[41] M. Feres, L. C. Figueiredo, I. M. Barreto, M. H. Coelho, M. W. Araujo, and S. C. J. Cortelli, "In vitro antimicrobial activity of plant extracts and propolis in saliva samples of healthy and periodontally-involved subjects," International Academy of Periodontology, vol. 7, no. 3, pp. 90-96, 2005.

[42] N. Malhotra, S. P. Rao, S. Acharya, and B. Vasudev, "Comparative in vitro evaluation of efficacy of mouthrinses against Streptococcus mutans, Lactobacilli and Candida albicans," Oral Health & Preventive Dentistry, vol. 9, no. 3, pp. 261-268, 2011.

[43] C. Anauate-Netto, M. C. Marcucci, N. Paulino et al., "Effects of typified propolis on mutans streptococci and lactobacilli: a randomized clinical trial," Brazilian Dental Science, vol. 16, no. 2, pp. 31-36, 2013.

[44] W. Krol, Z. Czuba, S. Scheller, J. Gabrys, S. Grabiec, and J. Shani, "Anti-oxidant property of ethanolic extract of propolis (EEP) as evaluated by inhibiting the chemiluminescence oxidation of luminol," Biochemistry International, vol. 21, no. 4, pp. 593-597, 1990.

[45] D. Skaba, T. Morawiec, M. Tanasiewicz et al., "Influence of the toothpaste with brazilian ethanol extract propolis on the oral cavity health," Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 215391, 12 pages, 2013.

[46] A. Machorowska-Pieniazek, T. Morawiec, A. Mertas, M. Tanasiewicz, A. Dziedzic, and W. Krol, "Influence of propolis on hygiene, gingival condition, and oral microflora in patients with cleft lip and palate treated with fixed orthodontic appliances," Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 183915, 9 pages, 2013.

[47] A. Machorowska-Pieniazek, M. Skucha-Nowak, A. Mertas et al., "Effects of brazilian propolis on dental plaque and gingiva in patients with oral cleft malformation treated with multibracket and removable appliances: A Comparative Study," Evidence-Based Complementary and Alternative Medicine, vol. 2016, pp. 1-10, 2016.

[48] H. Cao, G. Yang, Y. Wang et al., "Complementary therapies for acne vulgaris," The Cochrane Database of Systematic Reviews, vol. 1, Article ID CD009436, 2015.

[49] N. Pazyar, R. Yaghoobi, N. Bagherani, and A. Kazerouni, "A review of applications of tea tree oil in dermatology," International Journal of Dermatology, vol. 52, no. 7, pp. 784-790, 2013.

[50] C. F. Carson, K. A. Hammer, and T. V. Riley, "Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties," Clinical Microbiology Reviews, vol. 19, no. 1, pp. 50-62, 2006.

[51] K. A. Hammer, L. Dry, M. Johnson, E. M. Michalak, C. F. Carson, and T. V. Riley, "Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro," Oral Microbiology and Immunology, vol. 18, no. 6, pp. 389-392, 2003.

[52] P. De Camargo Smolarek, L. A. Esmerino, A. C. Chibinski, M. C. Bortoluzzi, E. B. D. Santos, and V. A. Kozlowski, "In vitro antimicrobial evaluation of toothpastes with natural compounds," European Journal of Dentistry, vol. 9, no. 4, pp. 580-586, 2015.

[53] J. Sokolowski, M. I. Szynkowska, J. Kleczewska et al., "Evaluation of resin composites modified with nanogold and nanosilver," Acta of Bioengineering and Biomechanics, vol. 16, no. 1, pp. 51-61, 2014.

[54] K. Sokolowski, M. I. Szynkowska, A. Pawlaczyk, M. Lukomska-Szymanska, and J. Sokolowski, "The impact of nanosilver addition on element ions release form light-cured dental composite and compomer into 0.9% NaCl," Acta Biochimica Polonica, vol. 61, no. 2, pp. 317-323, 2014.

[55] G. Ramage, K. Tomsett, B. L. Wickes, J. L. Lopez-Ribot, and S. W. Redding, "Denture stomatitis: a role for Candida biofilms," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 98, no. 1, pp. 53-59, 2004.

[56] A. J. Kurnatowska and J. Bieniek, "The level of cariogenic bacteria in wearers of partial dentures," Prosthetics, vol. 56, pp. 130-135, 2006.

[57] A. Kanli, F. Demirel, and Y. Sezgin, "Oral candidosis, denture cleanliness and hygiene habits in an elderly population," Aging Clinical and Experimental Research, vol. 17, no. 6, pp. 502-507, 2005.

[58] A. N. Koc, S. Silici, F. Kasap, H. T. Hormet-Oz, H. Mavus-Buldu, and B. D. Ercal, "Antifungal activity of the honeybee products against Candida spp. and Trichosporon spp.," Journal of Medicinal Food, vol. 14, no. 1-2, pp. 128-134, 2011.

[59] K. A. Hammer, C. F. Carson, and T. V. Riley, "Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil," Journal of Applied Microbiology, vol. 95, no. 4, pp. 853-860, 2003.

[60] K. A. Hammer, C. F. Carson, and T. V. Riley, "Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae," Journal of Antimicrobial Chemotherapy, vol. 53, no. 6, pp. 1081-1085, 2004.

[61] A. N. Sudjana, C. F. Carson, K. C. Carson, T. V. Riley, and K. A. Hammer, "Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil," Medical Mycology, vol. 87, no. 8, pp. 863-870, 2012.

Karolina Wiatrak, (1) Tadeusz Morawiec, (1) Rafal Roj, (2) Anna Mertas, (3) Agnieszka Machorowska-Pienidhek, (4) Patryk Kownacki, (1) Marta Tanasiewicz, (5) MaBgorzata Skucha-Nowak, (5) Stefan Baron, (6) Tomasz Piekarz, (1) Maciej Wrzol, (1) Mateusz Bogacz, (1) Jacek Kasperski, (2) and Iwona Niedzielska (7)

(1) Department of Oral Surgery, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Akademicki 17, 41-902 Bytom, Poland

(2) Department of Prosthetic Dentistry, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Akademicki 17, 41-902 Bytom, Poland

(3) Department of Microbiology and Immunology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Jordana 19, 41-808 Zabrze, Poland

(4) Department of Orthodontics, Chair of Masticatory Dysfunction and Orthodontics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Traugutta 2, 41-800 Zabrze, Poland

(5) Department of Conservative Dentistry with Endodontics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Akademicki 17, 41-902 Bytom, Poland

(6) Chair of Masticatory Dysfunction and Orthodontics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Traugutta 2, 41-800 Zabrze, Poland

(7) Department and Hospital of Craniomaxillofacial Surgery and Oral Surgery, School of Medicine with theDivision of Dentistry in Zabrze, Medical University of Silesia in Katowice, Plac Akademicki 17, 41-902 Bytom, Poland

Correspondence should be addressed to Rafal Roj;

Received 21 October 2016; Accepted 23 November 2016; Published 6 February 2017

Academic Editor: Vassya Bankova

Caption: Figure 1: ANOVA Estimated Marginal Means for denture plaque index study and control group.
Table 1: API ranges: assessment for study and control groups.

                                      Oral hygiene assessment
                                      (interproximal spaces)

                    The assessment       T1         T2         T3

                        Optimal         11%        39%        56%
                      Quite good        15%        28%        44%
Study group (A)         Average         53%        33%         0%
                          Bad           21%         0%         0%

                        Optimal         17%        21%        42%
                      Quite good        11%        37%        37%
Control group (C)       Average         72%        42%        21%
                          Bad            0%         0%         0%

Mann-Whitney "U"                      0.784483   0.046554   0.001032
test (p)

                    The assessment     Friedman's ANOVA test
                       criteria      (p)/Kendalls coefficient
                                          of concordance
                      Quite good
Study group (A)         Average
                          Bad           p = 0.0000/0.95894

                      Quite good
Control group (C)       Average
                          Bad           p = 0.00228/0.32012

Mann-Whitney "U"
test (p)                                        --

                    The assessment     Wilcoxon signed-
                       criteria          rank test p

                      Quite good
Study group (A)         Average       (1):(2) = 0.000438
                          Bad         (2):(3) = 0.000293
                                      (1):(3) = 0.000196

                      Quite good
Control group (C)       Average       (1):(2) = 0.231060
                          Bad         (2):(3) = 0.064186
                                      (1):(3) = 0.000327

Mann-Whitney "U"
test (p)                                      --

T1 (1): preliminary examination before hygiene procedure; T2 (2):
examination after 7 days; T3 (3): 28 days after the initial

Table 2: OHI ranges: assessment for study and control groups.

                        Oral hygiene assessment (interproximal spaces)

                                        Mean [+ or -]
                         T1               standard

                   0-0.5    55.5%
Study group (A)    0.6-1    44.5%     0.41 [+ or -] 0.25
                   1.1-2      0%
                   2.1-3      0%

                   0-0.5     58%
Control group      0.6-1     21%      0.64 [+ or -] 0.50
(C)                1.1-2     16%
                   2.1-3      5%

Study (A) versus           0.097301
control (C) (p)

            Oral hygiene assessment (interproximal spaces)

                                             Mean [+ or -]
                          T2                    standard         p

                    0-0.5      66.6%
Study group (A)     0.6-1      34.4%     0.33 [+ or -] 0.23   0.013221
                    1.1-2        0%
                    2.1-3        0%

                    0-0.5       63%
Control group       0.6-1       21%      0.58 [+ or -] 0.30   0.352356
(C)                 1.1-2       16%
                   0.006370   0.000002

Study (A) versus              0,006370
control (C) (p)

                                        Mean [+ or -]
                          T3             standard           p

                     0-0.5   88.8%
Study group (A)      0.6-1   11.1%   0.20 [+ or -] 0.17   0.000468
                     1.1-2    0%
                     2.1-3    0%

                     0-0.5   68.4%
Control group        0.6-1   31.6%   0.57 [+ or -] 0.23   0.382331
(C)                  1.1-2    0%
                     2.1-3    0%

Study (A) versus                          0,000002
control (C) (p)

T1 (1): preliminary examination before hygiene procedure; T2 (2):
examination after 7 days; T3 (3): 28 days after the initial

Table 3: SBI ranges: assessment for study and control groups.

                                     Sulcus Bleeding Index assessment

                     The assessment
                        criteria            T1         T2         T3

                     Normal gingiva        50%       72.5%       100%
Study group (A)         SBI < 10%
                   Bleeding on probing     50%       27.5%        0%

                     Normal gingiva        53%       65.5%      65.5%
Control group (C)       SBI < 10%
                   Bleeding on probing     47%       34.5%      34.5%
Mann-Whitney U                           0.346197   0.012713   0.000001
test (p)

                     The assessment        Friedman's ANOVA test
                        criteria         (p)/Kendall's coefficient
                                              of concordance

                     Normal gingiva
Study group (A)         SBI < 10%           p = 0.00000/0.71010
                   Bleeding on probing

                     Normal gingiva
Control group (C)       SBI < 10%           p = 0.09760/0.12247
                   Bleeding on probing
Mann-Whitney U
test (p)

                     The assessment
                        criteria          Wilcoxon signed-
                                             rank test p

                     Normal gingiva       (1):(2): 0.003283
Study group (A)         SBI < 10%         (2):(3): 0.001474
                   Bleeding on probing    (1):(3): 0.000982

                     Normal gingiva       (1):(2): 0.726768
Control group (C)       SBI < 10%         (2):(3): 0.286004
                   Bleeding on probing    (1):(3): 0.572082
Mann-Whitney U                                   --
test (p)

T1 (1): preliminary examination before hygiene procedure;
T2 (2): examination after 7 days; T3 (3): 28 days after the
initial examination.

Table 4: The microorganisms species isolated from patients, who used
toothpaste with EEP and TTO (study group, A) or without EEP and
TTO (control group, C).

                            Number of patients from study
                            group (A)
microorganisms              Initial   After    After
                                      7 days   28 days

Gram(+) anaerobic
Actinomyces viscosus           1        1         0
Actinomyces israelii           1        1         0
Actinomyces naeslundii         1        2         1
Anaerococcus prevotti          0        0         0
Atopobium minutum              0        0         1
Atopobium parvulum             1        0         0
Bifidobacterium                2        1         1
Bifidobacterium dentium        1        0         1
Bifidobacterium longum         4        5         4
Bifidobacterium breve          0        0         0
Bifidobacterium ovatus         3        2         0
Blautia producta               1        0         2
Clostridium barati             1        1         1
Clostridium botulinum          1        1         0
biovar A
Clostridium butyricum          0        0         1
Clostridium chauvoei           0        1         0
Clostridium                    0        0         0
Clostridium histolyticum       0        1         0
Clostridium perfringens        0        1         0
Clostridium sporogenes         0        0         0
Eubacterium saburreum          1        1         0
Gemella morbillorum            0        0         0
Lactobacillus acidophilus      1        0         0
Lactobacillus fermentum        1        1         0
Propionibacterium              1        1         0
Propionibacterium              0        0         0

Gram(-) anaerobic
Bacteroides ovatus             0        0         0
Bacteroides uniformis          1        0         0
Campylobacter gracilis         0        0         0
Capnocytophaga ochracea        0        1         1
Fusobacterium nucleatum        1        1         1
Fusobacterium mortiferum       0        0         0
Mitsuokella multacida          3        3         4
Parabacteroides                1        1         0
Prevotella melaninogenica      0        0         1
Prevotella oralis              0        0         0
Veillonella parvula            2        3         1

Gram(+) aerobic
Micrococcus spp.               0        0         1
Staphylococcus aureus          1        0         2
Staphylococcus                 1        0         0
epidermidis MSCNS
Streptococcus mitis            7        10        7
Streptococcus oralis           0        1         1
Streptococcus mutans           0        0         0
Streptococcus salivarius       9        5         8
Streptococcus sanguinis        4        5         2

Gram(-) aerobic
Acinetobacter freundii         1        0         0
Burkholderia cepacia           1        0         0
Enterobacter amniogenus        0        1         0
Enterobacter cloacae           0        1         0
Enterobacter spp.              0        0         0
Escherichia coli               0        0         0
Neisseria sicca                1        0         0
Neisseria subflava            15        18       16
Providencia rustigiani         0        0         1
Pseudomonas spp.               0        0         0
Stenotrophomonas               0        0         1

Candida albicans               8        8         6

Number of microorganisms      77        78       65
Altogether:                            220

                            Number of patients from control
                                      group (C)
microorganisms              I Initial   After    After
                                        7 days   28 days

Gram(+) anaerobic
Actinomyces viscosus            0        0         0
Actinomyces israelii            2        3         3
Actinomyces naeslundii          3        7         7
Anaerococcus prevotti           0        1         0
Atopobium minutum               0        1         0
Atopobium parvulum              0        0         0
Bifidobacterium                 1        0         1
Bifidobacterium dentium         0        1         3
Bifidobacterium longum          0        1         0
Bifidobacterium breve           5        2         5
Bifidobacterium ovatus          0        0         1
Blautia producta                2        0         1
Clostridium barati              0        2         0
Clostridium botulinum           0        0         0
biovar A
Clostridium butyricum           0        0         0
Clostridium chauvoei            0        0         1
Clostridium                     2        1         1
Clostridium histolyticum        0        0         0
Clostridium perfringens         1        1         1
Clostridium sporogenes          1        0         0
Eubacterium saburreum           1        0         0
Gemella morbillorum             0        0         1
Lactobacillus acidophilus       3        3         1
Lactobacillus fermentum         1        1         0
Propionibacterium               0        1         0
Propionibacterium               0        1         1

Gram(-) anaerobic
Bacteroides ovatus              1        0         0
Bacteroides uniformis           1        0         0
Campylobacter gracilis          1        1         2
Capnocytophaga ochracea         3        2         1
Fusobacterium nucleatum         0        1         0
Fusobacterium mortiferum        1        0         0
Mitsuokella multacida           5        4         5
Parabacteroides                 0        0         0
Prevotella melaninogenica       0        0         0
Prevotella oralis               1        0         0
Veillonella parvula             0        1         1

Gram(+) aerobic
Micrococcus spp.                0        0         0
Staphylococcus aureus           1        0         0
Staphylococcus                  0        0         0
epidermidis MSCNS

Streptococcus mitis             6        7         9
Streptococcus oralis            0        0         0
Streptococcus mutans            0        0         2
Streptococcus salivarius        7        4        10
Streptococcus sanguinis         5        7         3

Gram(-) aerobic
Acinetobacter freundii          0        0         0
Burkholderia cepacia            1        0         1
Enterobacter amniogenus         0        0         0
Enterobacter cloacae            0        0         0
Enterobacter spp.               0        1         0
Escherichia coli                1        1         2
Neisseria sicca                 0        2         1
Neisseria subflava             18        16       19
Providencia rustigiani          0        0         0
Pseudomonas spp.                0        1         0
Stenotrophomonas                0        0         0

Candida albicans                5        9         9

Number of microorganisms       79        83       92
Altogether:                             254

Table 5: The changes of oral microflora from patients, who used
toothpaste with EEP and TTO (study group, A) or without EEP and TTO
(control group, C).

Changes of                   Study group (A)
species after
28 days of study

                          Actinomyces viscosus
                          Actinomyces israelii
                           Atopobium parvulum
                         Bifidobacterium ovatus
                          Clostridium botulinum
                          Eubacterium saburreum
                        Lactobacillus acidophilus
                         Lactobacillus fermentum
                          Bacteroides uniformis
                       Parabacteroides dystasonis

                    Staphylococcus epidermidis MSCNS

                         Acinetobacter freundii
                          Burkholderia cepacia
                             Neisseria sicca

                      Bifidobacterium adolescentis

Declined                   Veillonella parvula

                        Streptococcus salivarius
                         Streptococcus sanguinis

                            Candida albicans

                            Atopobium minutum
                          Clostridium butyricum

species            Capnocytophaga ochracea Prevotella

                            Micrococcus spp.
                          Streptococcus oralis

                         Providiencia rustigiani
                      Stenotrophomonas maltophilia

                            Blautia producta

Increased                Mitsuokella multiacida

                       Staphylococcus aureus MSSA

                           Neisseria subflava


Changes of                                        Control group (C)
species after
28 days of study

                        Gram(+) anaerobic

                                               Clostridium sporogenes
                                                Eubacterium saburreum
                                               Lactobacillus fermentum

Eliminated              Gram(-) anaerobic
species                      bacteria            Bacteroides ovatus
                                                  Prevotella oralis

                         Gram(+) aerobic
                             bacteria          Staphylococcus aureus
                         Gram(-) aerobic
                        Gram(+) anaerobic
                             bacteria             Blautia producta
                                              Lactobacillus acidophilus
                        Gram(-) anaerobic
Declined                                           Capnocytophaga
species                                               ochracea

                         Gram(+) aerobic
                             bacteria          Streptococcus sanguinis


                        Gram(+) anaerobic
                             bacteria          Bifidobacterium dentium
                                               Bifidobacterium ovatus
                                                Clostridium chauvoei
                                                 Gemella morbillorum
Gained                  Gram(-) anaerobic
species                     bacteria            Veillonella parvula

                         Gram(+) aerobic
                             bacteria           Streptococcus mutans

                         Gram(-) aerobic
                             bacteria              Neisseria sicca

                        Gram(+) anaerobic
                             bacteria            Actinomyces israeli
                                               Actinomyces naeslundii
                        Gram(-) anaerobic
Increased                    bacteria          Campylobacter gracilis
                         Gram(+) aerobic
                             bacteria            Streptococcus mitis
                                              Streptococcus salivarius

                         Gram(-) aerobic
                             bacteria            Neisseria subflava
                                                  Escherichia coli
                                                  Candida albicans
COPYRIGHT 2017 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Wiatrak, Karolina; Morawiec, Tadeusz; Roj, Rafal; Mertas, Anna; Machorowska- Pienidhek, Agnieszka; K
Publication:Evidence - Based Complementary and Alternative Medicine
Article Type:Report
Date:Jan 1, 2017
Previous Article:Rapid Screening of Chemical Constituents in Rhizoma Anemarrhenae by UPLC-Q-TOF/MS Combined with Data Postprocessing Techniques.
Next Article:Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |